Novavax’s Coronavirus Vaccine Enters Late-Stage Trials

Novavax has started the phase 3 trial for its experimental coronavirus vaccine in the United Kingdom, where a surge of coronavirus infections should provide good conditions for the trial, making it the fifth vaccine candidate funded by the Trump administration’s Operation Warp Speed to enter late-stage testing.